The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study

Study objective: Hypertrophic cardiomyopathy (HCM) is the most common genetic myocardial disorder increasingly characterized by concomitant metabolic syndrome. Cardiac rehabilitation (CR) has been shown to improve metabolic parameters in populations with heart failure and myocardial infarction. Howe...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew Cheung, Nathaniel Moulson, Jinelle C. Gelinas, Ali Daraei, Sarah M. Bradwell, Carolyn Taylor, Neil D. Eves, Graeme J. Koelwyn, Thomas M. Roston
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:American Heart Journal Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602225000047
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199296662732800
author Matthew Cheung
Nathaniel Moulson
Jinelle C. Gelinas
Ali Daraei
Sarah M. Bradwell
Carolyn Taylor
Neil D. Eves
Graeme J. Koelwyn
Thomas M. Roston
author_facet Matthew Cheung
Nathaniel Moulson
Jinelle C. Gelinas
Ali Daraei
Sarah M. Bradwell
Carolyn Taylor
Neil D. Eves
Graeme J. Koelwyn
Thomas M. Roston
author_sort Matthew Cheung
collection DOAJ
description Study objective: Hypertrophic cardiomyopathy (HCM) is the most common genetic myocardial disorder increasingly characterized by concomitant metabolic syndrome. Cardiac rehabilitation (CR) has been shown to improve metabolic parameters in populations with heart failure and myocardial infarction. However, there is a paucity of data on the impact of CR in the HCM population with metabolic syndrome. We designed the REHAB-HCM study to explore the feasibility, safety, and efficacy of CR in HCM patients with metabolic syndrome. Design: Prospective observation cohort study. Setting: A multi-disciplinary HCM clinic and Multidisciplinary Exercise-based Cardiac Rehabilitation program. Participants: Patients aged 18–80 years old diagnosed with HCM and metabolic syndrome, defined by the American Heart Association and American College of Cardiology guidelines, and the National Cholesterol Education Adult Treatment Panel III (NCEP-ATP III) criteria. Intervention: A structured 3-month CR program with 6 months extended follow-up of physical activity levels. Main outcome measures: Feasibility (e.g., attendance), safety (e.g., major adverse events and exercise-related harms), and efficacy pertaining to long term improvements in physical activity levels, metabolic health, cardiorespiratory fitness, quality of life, and systemic and cellular markers of inflammation. Conclusion: This prospective cohort study will address an important knowledge gap by evaluating the effect of an organized CR program in HCM patients and metabolic syndrome. It is anticipated that exercise and CR will be feasible and beneficial for this complex patient population without significant exercise-related harms.
format Article
id doaj-art-e099da00ec5f48a2ac6cd87a9946f605
institution Kabale University
issn 2666-6022
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series American Heart Journal Plus
spelling doaj-art-e099da00ec5f48a2ac6cd87a9946f6052025-02-08T05:01:22ZengElsevierAmerican Heart Journal Plus2666-60222025-02-0150100501The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) StudyMatthew Cheung0Nathaniel Moulson1Jinelle C. Gelinas2Ali Daraei3Sarah M. Bradwell4Carolyn Taylor5Neil D. Eves6Graeme J. Koelwyn7Thomas M. Roston8Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDivision of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, CanadaCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada; Centre for Heart, Lung and Vascular Health, School of Health and Exercise Sciences, University of British Columbia, Kelowna, CanadaCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, CanadaDivision of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaCentre for Heart, Lung and Vascular Health, School of Health and Exercise Sciences, University of British Columbia, Kelowna, CanadaCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, CanadaDivision of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Cardiovascular Innovation, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Corresponding author at: St. Paul's Hospital, Division of Cardiology, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada.Study objective: Hypertrophic cardiomyopathy (HCM) is the most common genetic myocardial disorder increasingly characterized by concomitant metabolic syndrome. Cardiac rehabilitation (CR) has been shown to improve metabolic parameters in populations with heart failure and myocardial infarction. However, there is a paucity of data on the impact of CR in the HCM population with metabolic syndrome. We designed the REHAB-HCM study to explore the feasibility, safety, and efficacy of CR in HCM patients with metabolic syndrome. Design: Prospective observation cohort study. Setting: A multi-disciplinary HCM clinic and Multidisciplinary Exercise-based Cardiac Rehabilitation program. Participants: Patients aged 18–80 years old diagnosed with HCM and metabolic syndrome, defined by the American Heart Association and American College of Cardiology guidelines, and the National Cholesterol Education Adult Treatment Panel III (NCEP-ATP III) criteria. Intervention: A structured 3-month CR program with 6 months extended follow-up of physical activity levels. Main outcome measures: Feasibility (e.g., attendance), safety (e.g., major adverse events and exercise-related harms), and efficacy pertaining to long term improvements in physical activity levels, metabolic health, cardiorespiratory fitness, quality of life, and systemic and cellular markers of inflammation. Conclusion: This prospective cohort study will address an important knowledge gap by evaluating the effect of an organized CR program in HCM patients and metabolic syndrome. It is anticipated that exercise and CR will be feasible and beneficial for this complex patient population without significant exercise-related harms.http://www.sciencedirect.com/science/article/pii/S2666602225000047Hypertrophic cardiomyopathyCardiac rehabilitationMetabolic syndromeCardiometabolic fitnessExercise therapyInflammation
spellingShingle Matthew Cheung
Nathaniel Moulson
Jinelle C. Gelinas
Ali Daraei
Sarah M. Bradwell
Carolyn Taylor
Neil D. Eves
Graeme J. Koelwyn
Thomas M. Roston
The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
American Heart Journal Plus
Hypertrophic cardiomyopathy
Cardiac rehabilitation
Metabolic syndrome
Cardiometabolic fitness
Exercise therapy
Inflammation
title The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
title_full The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
title_fullStr The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
title_full_unstemmed The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
title_short The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
title_sort design and rationale of the cardiac rehabilitation to improve metabolic health in hypertrophic cardiomyopathy rehab hcm study
topic Hypertrophic cardiomyopathy
Cardiac rehabilitation
Metabolic syndrome
Cardiometabolic fitness
Exercise therapy
Inflammation
url http://www.sciencedirect.com/science/article/pii/S2666602225000047
work_keys_str_mv AT matthewcheung thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT nathanielmoulson thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT jinellecgelinas thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT alidaraei thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT sarahmbradwell thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT carolyntaylor thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT neildeves thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT graemejkoelwyn thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT thomasmroston thedesignandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT matthewcheung designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT nathanielmoulson designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT jinellecgelinas designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT alidaraei designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT sarahmbradwell designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT carolyntaylor designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT neildeves designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT graemejkoelwyn designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy
AT thomasmroston designandrationaleofthecardiacrehabilitationtoimprovemetabolichealthinhypertrophiccardiomyopathyrehabhcmstudy